SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-310086
Filing Date
2014-08-14
Accepted
2014-08-14 15:59:50
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d762522d10q.htm 10-Q 585166
2 EX-31.1 d762522dex311.htm EX-31.1 8857
3 EX-31.2 d762522dex312.htm EX-31.2 8853
4 EX-32.1 d762522dex321.htm EX-32.1 6059
  Complete submission text file 0001193125-14-310086.txt   2992735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sage-20140630.xml EX-101.INS 309534
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20140630.xsd EX-101.SCH 26734
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20140630_cal.xml EX-101.CAL 34557
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20140630_def.xml EX-101.DEF 121764
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20140630_lab.xml EX-101.LAB 259192
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20140630_pre.xml EX-101.PRE 189306
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 141042503
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences